相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score
Javier Cobo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection
Rodrigo Rodrigues et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital
Marie Pichenot et al.
INFECTION (2017)
Prediction of Recurrent Clostridium Difficile Infection Using Comprehensive Electronic Medical Records in an Integrated Healthcare Delivery System
Gabriel J. Escobar et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?
Ferric C. Fang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
M. H. Wilcox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence
Swati B. Gupta et al.
CLINICAL INFECTIOUS DISEASES (2016)
Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013
K. A. Davies et al.
EUROSURVEILLANCE (2016)
Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review
Brandon C. Chapman et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2016)
Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection
Anna Maria Seekatz et al.
GENOME MEDICINE (2016)
Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review
Brandon C. Chapman et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2016)
Clostridium difficile Ribotype 027: Relationship to Age, Detectability of Toxins A or B in Stool With Rapid Testing, Severe Infection, and Mortality
Krishna Rao et al.
CLINICAL INFECTIOUS DISEASES (2015)
Evaluation of Portability and Cost of a Fluorescent PCR Ribotyping Protocol for Clostridium difficile Epidemiology
Jonathan N. V. Martinson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients
Colleen R. Kelly et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Host-Pathogen Interactions in Clostridium difficile Infection: It Takes Two to Tango
David M. Aronoff
CLINICAL INFECTIOUS DISEASES (2014)
Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors
Ralph B. D'Agostino et al.
CLINICAL INFECTIOUS DISEASES (2014)
A Mathematical Model to Evaluate the Routine Use of Fecal Microbiota Transplantation to Prevent Incident and Recurrent Clostridium difficile Infection
Eric T. Lofgren et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2014)
Development and Validation of a Recurrent Clostridium difficile Risk-Prediction Model
Marya D. Zilberberg et al.
JOURNAL OF HOSPITAL MEDICINE (2014)
Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review
Claire Nour Abou Chakra et al.
PLOS ONE (2014)
The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates
Paul E. Carlson et al.
ANAEROBE (2013)
Is Fidaxomicin Worth the Cost? An Economic Analysis
Sarah M. Bartsch et al.
CLINICAL INFECTIOUS DISEASES (2013)
Detection of Mixed Populations of Clostridium difficile from Symptomatic Patients Using Capillary-Based Polymerase Chain Reaction Ribotyping
Adam A. Behroozian et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Predicting Recurrence of C-difficile Colitis Using Bacterial Virulence Factors: Binary Toxin Is the Key
David B. Stewart et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
MissForest-non-parametric missing value imputation for mixed-type data
Daniel J. Stekhoven et al.
BIOINFORMATICS (2012)
Decreased Cure and Increased Recurrence Rates for Clostridium difficile Infection Caused by the Epidemic C. difficile BI Strain
Laurica A. Petrella et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
Derrick W. Crook et al.
CLINICAL INFECTIOUS DISEASES (2012)
Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
David W. Eyre et al.
CLINICAL INFECTIOUS DISEASES (2012)
Association of Relapse of Clostridium difficile Disease with BI/NAP1/027
Jane W. Marsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
Brett A. Leav et al.
VACCINE (2010)
Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection
Mary Y. Hu et al.
GASTROENTEROLOGY (2009)
Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea
Ju Young Chang et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Recommendations for surveillance of Clostridium difficile-associated disease
L. Clifford McDonald et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
L Kyne et al.
LANCET (2001)